0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Anthracycline Antibiotics in Cancer Therapy - Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer Therapy, New York, New York, 16-18 September 1981 (Paperback, Softcover reprint of the original 1st ed. 1982) Loot Price: R1,651
Discovery Miles 16 510
Anthracycline Antibiotics in Cancer Therapy - Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer...

Anthracycline Antibiotics in Cancer Therapy - Proceedings of the International Symposium on Anthracycline Antibiotics in Cancer Therapy, New York, New York, 16-18 September 1981 (Paperback, Softcover reprint of the original 1st ed. 1982)

Franco M. Muggia, Charles W. Young, Stephen K. Carter

Series: Developments in Oncology, 10

 (sign in to rate)
Loot Price R1,651 Discovery Miles 16 510 | Repayment Terms: R155 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Donate to Gift Of The Givers

F. M. MUGGIA When faced with the inadequacies of current cancer treatment, we prefer to look at what the future may hold. Quite often, we take for granted the past, preferring research into totally new areas. However, the persistent development of fertile soil may yield surprising rewards for those who choose to build on the knowledge of the past--hence, this symposium on anthracycline antibiotics. Although the anthracycline antibiotics represent much of the present and future of cancer treatment, their actual use c stretches back barely two decades to the pioneering efforts of Aurelio Di Marco, who characterized the antitumor properties of daunomycin and adriamycin. * The clinical application of these two compounds heralded a decade of excitement among oncologists dealing with pediatric tumors, breast cancer, leukemias, and lymphomas, and opened new hope for patients afflicted with sar comas and a variety of other tumors that had been deemed - sistant to chemotherapy. These successes were tempered with the realization that the antitumor effect of anthracyclines could be achieved at times only at the very high price of risking cardiac decompensation and, almost invariably, with the occurrence of alopecia and other acute toxicities. This record of past achievements and problems has slowly given way to a present increasingly illuminated by our ability to modify the distressing toxicities of these agents. Detailed clinical studies supplemented by ingenious laboratory models have gradually elucidated mechanisms and risk factors im plicated in the cardiomyopathy."

General

Imprint: Springer
Country of origin: Netherlands
Series: Developments in Oncology, 10
Release date: March 2012
First published: 1982
Editors: Franco M. Muggia • Charles W. Young • Stephen K. Carter
Dimensions: 235 x 155 x 30mm (L x W x T)
Format: Paperback
Pages: 568
Edition: Softcover reprint of the original 1st ed. 1982
ISBN-13: 978-9400976320
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 9400976321
Barcode: 9789400976320

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners